Skip to main content

Advertisement

SpringerLink
Log in

BCG Vaccine–Associated Complications in Patients with PTEN Hamartoma Tumor Syndrome

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract United States. 2020;8:1371–86.

    Article  Google Scholar 

  2. Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med Annual Reviews. 2020;71:103–16.

    Article  CAS  Google Scholar 

  3. Taylor H, Laurence ADJ, Uhlig HH. The role of PTEN in innate and adaptive immunity. Cold Spring Harb Perspect Med. 2019;9(12):a036996.

    Article  CAS  Google Scholar 

  4. Chen HH, Händel N, Ngeow J, Muller J, Hühn M, Yang HT, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol Elsevier. 2017;139:607-620.e15.

    Article  CAS  Google Scholar 

  5. Heindl M, Handel N, Ngeow J, Kionke J, Wittekind C, Kamprad M, et al. Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome. Gastroenterology United States. 2012;142:1093-1096.e6.

    Google Scholar 

  6. Taylor H, Yerlioglu D, Phen C, Ballauff A, Nedelkopolou N, Spier I, et al. mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in juvenile polyposis of infancy due to PTEN-BMPR1A deletion syndrome. Hum Mol Genet. 2021;30(14):1273.

  7. Garcia-Prat M, Álvarez-Sierra D, Aguiló-Cucurull A, Salgado-Perandrés S, Briongos-Sebastian S, Franco-Jarava C, et al. Extended immunophenotyping reference values in a healthy pediatric population. Cytom Part B Clin Cytom John Wiley & Sons, Ltd. 2019;96:223–33.

    Article  CAS  Google Scholar 

  8. Garcia-Prat M, Vila-Pijoan G, Martos Gutierrez S, Gala Yerga G, García Guantes E, Martínez-Gallo M, et al. Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the OptiliteTM automated turbidimetric analyzer. J Clin Lab Anal Wiley Online Library. 2018;32:e22420.

    Article  Google Scholar 

  9. Tsujita Y, Mitsui-Sekinaka K, Imai K, Yeh TW, Mitsuiki N, Asano T, et al. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome–like immunodeficiency. J Allergy Clin Immunols Elsevier Inc. 2016;138:1672–80.

    Article  CAS  Google Scholar 

  10. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24–64.

  11. Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase & #x3b4; syndrome: A large patient cohort study. J Allergy Clin Immunol Elsevier. 2017;139:597-606.e4.

    Article  CAS  Google Scholar 

  12. Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase & #x3b4; syndrome 2: A cohort study. J Allergy Clin Immunol Elsevier. 2016;138:210-218.e9.

    Article  CAS  Google Scholar 

  13. Nunes-Santos CJ, Rosenzweig SD. Bacille Calmette-Guerin complications in newly described primary immunodeficiency Diseases: 2010–2017. Front Immunol Frontiers. 2018;9:1423.

  14. Chiriaco M, Brigida I, Ariganello P, Di Cesare S, Di Matteo G, Taus F, et al. The case of an APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment. Clin Immunol. 2017;178:20–8.

    Article  CAS  Google Scholar 

  15. Sloot YJE, Rabold K, Netea MG, Smit JWA, Hoogerbrugge N, Netea-Maier RT. Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome. Oncogene Nature Publishing Group. 2019;38(19):3743–55.

    CAS  Google Scholar 

  16. Huang GC, Redelman-Sidi G, Rosen N, Glickman MS, Jiang XJ. Inhibition of mycobacterial infection by the tumor suppressor PTEN. J Biol Chem. 2012;287:23196–202.

    Article  CAS  Google Scholar 

  17. Rosain J, Kong X-F, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014–2018 update. Immunol Cell Biol. 2019;97:360–7.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank the patients and their families for their contribution to this research.

Funding

HHU is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, and The Leona M. and Harry B. Helmsley Charitable Trust.

Author information

Authors and Affiliations

  1. Department of Surgery and Cancer, Imperial College London, London, UK

    Henry Taylor

  2. Translational Gastroenterology Unit, University of Oxford, Oxford, UK

    Dominik Aschenbrenner, Hannah Chen & Holm H. Uhlig

  3. Paediatric Gastroenterology, Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, UK

    Mike Thomson

  4. Department of Paediatrics, University of Oxford, Oxford, UK

    Holm H. Uhlig

  5. Oxford NIHR Biomedical Research Centre, Oxford, UK

    Holm H. Uhlig

Authors
  1. Henry Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dominik Aschenbrenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mike Thomson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hannah Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Holm H. Uhlig
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HHU and MT provided clinical data. DA performed T cell phenotyping and HC performed phosphoflow analysis of T cell blasts. HT and HHU wrote and prepared the manuscript. DA, MT, and HC edited and reviewed the manuscript.

Corresponding author

Correspondence to Henry Taylor.

Ethics declarations

Ethical Approval and Informed Consent

Patients consented to clinical research via the Oxford GI biobank. They have consented to publication.

Conflict of Interest

HC and HHU received research support by UCB Pharma.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 608 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, H., Aschenbrenner, D., Thomson, M. et al. BCG Vaccine–Associated Complications in Patients with PTEN Hamartoma Tumor Syndrome . J Clin Immunol 41, 1701–1705 (2021). https://doi.org/10.1007/s10875-021-01100-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01100-9

Search

Navigation